ROSARIO
CALVO DUO
Forscher/in in der Zeit 1992-2011
Publikationen, an denen er mitarbeitet ROSARIO CALVO DUO (73)
2013
-
A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach
Pediatric Drugs, Vol. 15, Núm. 3, pp. 247-257
-
Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: Pharmacokinetic considerations and patient pathophysiology
International Journal of Clinical Pharmacology and Therapeutics, Vol. 51, Núm. 7, pp. 606-614
-
Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction
European Journal of Clinical Pharmacology, Vol. 69, Núm. 1, pp. 65-74
2012
-
Sulfato de glucosamina y condroitín sulfato, fármacos para el tratamiento de la artrosis, acusados de no presentar eficacia clínica. ¿Culpables?
Gaceta Medica de Bilbao, Vol. 109, Núm. 4, pp. 158-164
-
Sulfato de glucosamina y condroitín sulfato, fármacos para el tratamiento de la artrosis, acusados de no presentar eficacia clínica. ¿Culpables?
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 109, Núm. 4, pp. 158-164
2011
-
Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation
European Journal of Clinical Pharmacology, Vol. 67, Núm. 7, pp. 671-679
2010
-
Simulation of sirolimus exposures and population variability immediately post renal transplantation: Importance of the patient's CYP3A5 genotype in tailoring treatment
Biopharmaceutics and Drug Disposition, Vol. 31, Núm. 2-3, pp. 129-137
2007
-
Modeling methadone pharmacokinetics in rats in presence of P-glycoprotein inhibitor valspodar
Pharmaceutical Research, Vol. 24, Núm. 7, pp. 1299-1308
2006
-
The role of unbound drug in pharmacokinetics/pharmacodynamics and in therapy
Current Pharmaceutical Design, Vol. 12, Núm. 8, pp. 977-987
2005
-
Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus
Journal of Pharmacy and Pharmacology, Vol. 57, Núm. 3, pp. 317-325
-
Bicompartmental kinetics of tobramycin analysed with a wide range of covariates
International Journal of Antimicrobial Agents, Vol. 26, Núm. 4, pp. 304-311
-
Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: An integrated parent-metabolite model
Pharmaceutical Research, Vol. 22, Núm. 11, pp. 1769-1782
-
Time-dependent pharmacokinetics of cyclosporine (Neoral®) in de novo renal transplant patients
Journal of Clinical Pharmacy and Therapeutics, Vol. 30, Núm. 6, pp. 549-557
2004
-
Alpha-1-acid glycoprotein directly affects the pharmacokinetics and the analgesic effect of methadone in the rat beyond protein binding
Journal of Pharmaceutical Sciences, Vol. 93, Núm. 11, pp. 2836-2850
-
Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat
Journal of Pharmacy and Pharmacology, Vol. 56, Núm. 3, pp. 367-374
-
Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients
Acta Anaesthesiologica Scandinavica, Vol. 48, Núm. 8, pp. 1038-1048
2003
-
Age-related changes in pharmacokinetics and pharmacodynamics of lerisetron in the rat: A population pharmacokinetic model
Gerontology, Vol. 49, Núm. 4, pp. 205-214
-
Caso Pharmadatum: servicios innovadores en el campo de los análisis de datos procedentes de los ensayos preclínicos y clínicos farmacológicos
La creación de empresas de base tecnológica: una experiencia práctica (Centro Europeo de Empresas e Innovación de Navarra (CEIN)), pp. 115-122
-
Population pharmacokinetics of netilmicin in short-term prophylactic treatment
British Journal of Clinical Pharmacology, Vol. 55, Núm. 6, pp. 552-559
2002
-
'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction
European Journal of Clinical Pharmacology, Vol. 58, Núm. 9, pp. 615-619